2019
DOI: 10.1016/j.ijscr.2019.02.028
|View full text |Cite
|
Sign up to set email alerts
|

Male DCIS diagnosed after use of over-the-counter hormonal supplement

Abstract: HighlightsAs illustrated in this case report, male ductal carcinoma in-situ is a rare disease, and treatment is not standardized.Hormone-containing male enhancement supplements are unregulated and available over-the-counter.Hormonal supplementation may be related to the development or worsening of rare cases of male breast cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…One of our patients with a family history also had an alcohol use disorder and diabetes, and another had gynecomastia. Gynecomastia can be observed in 6-38% of men with breast cancer ( 16 ). Three of our patients (11.1%) had gynecomastia.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…One of our patients with a family history also had an alcohol use disorder and diabetes, and another had gynecomastia. Gynecomastia can be observed in 6-38% of men with breast cancer ( 16 ). Three of our patients (11.1%) had gynecomastia.…”
Section: Discussionmentioning
confidence: 99%
“…Although male breast cancer occurs in all age groups, it is frequently observed between 60 and 70 years of age on average (2,3,10,(12)(13)(14). Genetic factors, BRCA2 mutations, family history, obesity, Klinefelter's syndrome, gynecomastia, liver disease, orchitis, undescended testicle, alcohol use, exogenous estrogen and testosterone use, and radiation are accused in the etiology (1,8,9,(15)(16)(17). Patients mostly present with a painless mass, nipple discharge, skin ulceration, or nipple retraction (2,4).…”
Section: Introductionmentioning
confidence: 99%